The influence of vitamin D on the treatment outcome of (DM) TB

The influence and mechanism of vitamin D3 supplementation on the treatment outcomes of tuberculosis patients of different glucose tolerance

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15006395

Enrollment

Unknown

Registered

2015-05-13

Start date

2015-05-25

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tuberculosis (diabetes)

Interventions

NTB:vitamin D3

HTB:vitamin D3

NTB :control

HTB:control

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: new diagnosed tuberculosis, sputum smear positive, aged >=18, stable adress

Exclusion criteria

Exclusion criteria: HIV positive, tumor, pregnant or lactase women, injured lately, adjusted calcium concerntration >2.65mmol/L

Design outcomes

Primary

Measure	Time frame
treatment outcomes;CD4+/CD8+;quantity of life (SF-36v2);	—

Secondary

Measure	Time frame
oxidative stress;serum 25(OH)D;	—

Countries

China

Contacts

Public ContactWang Qiuzhen

kevin_1971@126.com+86 0532-82991503

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026